Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Paton

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
Open Heart|March 28, 2025
Echocardiography reporting in heart failure with preserved ejection fraction: Delphi consensus studyMaria F Paton, Carys Barton, Resham Baruah, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 22, 2005
Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive ratKathleen W Sellers, Chengwen Sun, Carlos Diez-Freire, et al.
Journal of Medical Microbiology|September 2, 2024
Lessons learned: drive-through COVID-19 clinic testing during an adaptive epidemic response and a point-of-care test assessment of a computer-read rapid lateral flow immunoassay with fluorescence-based detectionLeah Rankine-Wilson, Teresa Oncken, Irshan Basrewan, et al.
Journal of the American College of Cardiology|April 23, 2016
Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart FailureHaqeel A Jamil, John Gierula, Maria F Paton, et al.
Molecules (Basel, Switzerland)|October 14, 2018
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in RodentsBronwyn M Kivell, Kelly F Paton, Nitin Kumar, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 19, 2017
Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillatorMichael Drozd, John Gierula, Judith E Lowry, et al.
Echo Research and Practice|March 7, 2023
Atrial secondary mitral regurgitation: prevalence, characteristics, management, and long-term outcomesSam Straw, Ankit Gupta, Kerryanne Johnson, et al.
European Heart Journal Open|June 12, 2026
Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving <i>de novo</i> and replacement pacemaker therapy for bradycardiaNurul H Abdul Samad, John Gierula, Judith E Lowry, et al.
European Journal of Nutrition|August 20, 2018
Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failureRichard M Cubbon, Judith E Lowry, Michael Drozd, et al.
JACC. Heart Failure|December 12, 2017
Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart FailureJohn Gierula, Maria F Paton, Judith E Lowry, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Open Heart|March 28, 2025
Echocardiography reporting in heart failure with preserved ejection fraction: Delphi consensus studyMaria F Paton, Carys Barton, Resham Baruah, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 22, 2005
Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive ratKathleen W Sellers, Chengwen Sun, Carlos Diez-Freire, et al.
Journal of Medical Microbiology|September 2, 2024
Lessons learned: drive-through COVID-19 clinic testing during an adaptive epidemic response and a point-of-care test assessment of a computer-read rapid lateral flow immunoassay with fluorescence-based detectionLeah Rankine-Wilson, Teresa Oncken, Irshan Basrewan, et al.
Journal of the American College of Cardiology|April 23, 2016
Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart FailureHaqeel A Jamil, John Gierula, Maria F Paton, et al.
Molecules (Basel, Switzerland)|October 14, 2018
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in RodentsBronwyn M Kivell, Kelly F Paton, Nitin Kumar, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 19, 2017
Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillatorMichael Drozd, John Gierula, Judith E Lowry, et al.
Echo Research and Practice|March 7, 2023
Atrial secondary mitral regurgitation: prevalence, characteristics, management, and long-term outcomesSam Straw, Ankit Gupta, Kerryanne Johnson, et al.
European Heart Journal Open|June 12, 2026
Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving <i>de novo</i> and replacement pacemaker therapy for bradycardiaNurul H Abdul Samad, John Gierula, Judith E Lowry, et al.
European Journal of Nutrition|August 20, 2018
Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failureRichard M Cubbon, Judith E Lowry, Michael Drozd, et al.
JACC. Heart Failure|December 12, 2017
Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart FailureJohn Gierula, Maria F Paton, Judith E Lowry, et al.
Pageof 16